VALCYTE
Google image searchProduct monograph
Active ingredient
valganciclovir (valganciclovir hydrochloride), 50 MG/ML
DIN: 02306085
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: ORAL
Schedule: Prescription
Company: CHEPLAPHARM ARZNEIMITTEL GMBH
Date: 19-JUL-2022
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AB — Nucleosides and nucleotides excl. reverse transcriptase inhibitors (ATC, ATC/DDD)
- J05AB14 — VALGANCICLOVIR (ATC/DDD)
Reference brand drug: Valcyte
